New Age Alpha Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,867
Closed -$153K – 1020
2026
Q2
$153K Sell
4,867
-207
-4% -$6.11K 0.01% 797
2026
Q1
$126K Sell
5,074
-124
-2% -$2.95K 0.01% 666
2025
Q4
$121K Buy
+5,198
New +$116K 0.01% 668

Other funds holding CPRX

New Age Alpha Advisors's CPRX Position: Q3 2026 in Review

New Age Alpha Advisors sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 4,867 shares — an estimated $153K sold.

New Age Alpha Advisors first reported a position in CPRX in Q4 2025 and held it in 3 quarters. The position peaked at $153K in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

  • New Age Alpha Advisors reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • New Age Alpha Advisors sold 4,867 Catalyst Pharmaceutical shares in Q3 2026, an estimated $153K.
  • New Age Alpha Advisors first reported a position in Catalyst Pharmaceutical in Q4 2025 and held it in 3 quarters.
  • New Age Alpha Advisors's Catalyst Pharmaceutical position peaked at $153K in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on New Age Alpha Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.